|
1.
|
Jiang Y, Jahagirdar BN, Reinhardt RL, et
al: Pluripotency of mesenchymal stem cells derived from adult
marrow. Nature. 418:41–49. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Bianco P, Robey PG and Simmons PJ:
Mesenchymal stem cells: revisiting history, concepts, and assays.
Cell Stem Cell. 2:313–319. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Dominici M, Le Blanc K, Mueller I, et al:
Minimal criteria for defining multipotent mesenchymal stromal
cells. The International Society for Cellular Therapy position
statement. Cytotherapy. 8:315–317. 2006. View Article : Google Scholar
|
|
4.
|
Tropel P, Noel D, Platet N, Legrand P,
Benabid AL and Berger F: Isolation and characterisation of
mesenchymal stem cells from adult mouse bone marrow. Exp Cell Res.
295:395–406. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Zuk PA, Zhu M, Mizuno H, et al:
Multilineage cells from human adipose tissue: implications for
cell-based therapies. Tissue Eng. 7:211–228. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Jones EA, English A, Henshaw K, et al:
Enumeration and phenotypic characterization of synovial fluid
multipotential mesenchymal progenitor cells in inflammatory and
degenerative arthritis. Arthritis Rheum. 50:817–827. 2004.
View Article : Google Scholar
|
|
7.
|
Williams JT, Southerland SS, Souza J,
Calcutt AF and Cartledge RG: Cells isolated from adult human
skeletal muscle capable of differentiating into multiple mesodermal
phenotypes. Am Surg. 65:22–26. 1999.PubMed/NCBI
|
|
8.
|
Studeny M, Marini FC, Champlin RE,
Zompetta C, Fidler IJ and Andreeff M: Bone marrow-derived
mesenchymal stem cells as vehicles for interferon-beta delivery
into tumors. Cancer Res. 62:3603–3608. 2002.PubMed/NCBI
|
|
9.
|
Rattigan Y, Hsu JM, Mishra PJ, Glod J and
Banerjee D: Interleukin 6 mediated recruitment of mesenchymal stem
cells to the hypoxic tumor milieu. Exp Cell Res. 316:3417–3424.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Tu S, Bhagat G, Cui G, et al:
Overexpression of interleukin-1beta induces gastric inflammation
and cancer and mobilizes myeloid-derived suppressor cells in mice.
Cancer Cell. 14:408–419. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Quante M, Tu SP, Tomita H, et al: Bone
marrow-derived myofibroblasts contribute to the mesenchymal stem
cell niche and promote tumor growth. Cancer Cell. 19:257–272. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Gao H, Priebe W, Glod J and Banerjee D:
Activation of signal transducers and activators of transcription 3
and focal adhesion kinase by stromal cell-derived factor 1 is
required for migration of human mesenchymal stem cells in response
to tumor cell-conditioned medium. Stem Cells. 27:857–865. 2009.
View Article : Google Scholar
|
|
13.
|
Direkze NC, Hodivala-Dilke K, Jeffery R,
et al: Bone marrow contribution to tumor-associated myofibroblasts
and fibroblasts. Cancer Res. 64:8492–8495. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Zhang L, Tang A, Zhou Y, et al:
Tumor-conditioned mesenchymal stem cells display hematopoietic
differentiation and diminished influx of Ca2+. Stem
Cells Dev. 21:1418–1428. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Zhou Y, Guan X, Wang H, et al: Hypoxia
induces osteogenic/angiogenic responses of bone marrow-derived
mesenchymal stromal cells seeded on bone-derived scaffolds via
ERK1/2 and p38 pathways. Biotechnol Bioeng. Jan 7–2013.(Epub ahead
of print).
|
|
16.
|
Janeczek Portalska K, Leferink A, Groen N,
et al: Endothelial differentiation of mesenchymal stromal cells.
PLoS One. 7:e468422012.PubMed/NCBI
|
|
17.
|
Mishra PJ, Mishra PJ, Humeniuk R, Medina
DJ, et al: Carcinoma-associated fibroblast-like differentiation of
human mesenchymal stem cells. Cancer Res. 68:4331–4339. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Zuk PA, Zhu M, Ashjian P, et al: Human
adipose tissue is a source of multipotent stem cells. Mol Biol
Cell. 13:4279–4295. 2002.PubMed/NCBI
|
|
19.
|
Mosna F, Sensebé L and Krampera M: Human
bone marrow and adipose tissue mesenchymal stem cells: a user’s
guide. Stem Cells Dev. 19:1449–1470. 2010.
|
|
20.
|
Kidd S, Spaeth E, Watson K, et al: Origins
of the tumor microenvironment: quantitative assessment of
adipose-derived and bone marrow-derived stroma. PLoS One.
7:e305632012. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Song S, Ewald AJ, Stallcup W, Werb Z and
Bergers G: PDGFRbeta+ perivascular progenitor cells in tumours
regulate pericyte differentiation and vascular survival. Nat Cell
Biol. 7:870–879. 2005.
|
|
22.
|
McGrail DJ, Ghosh D, Quach ND and Dawson
MR: Differential mechanical response of mesenchymal stem cells and
fibroblasts to tumor-secreted soluble factors. PLoS One.
7:e332482012. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Wang D, Park JS, Chu JS, et al: Proteomic
profiling of bone marrow mesenchymal stem cells upon transforming
growth factor beta1 stimulation. J Biol Chem. 279:43725–43734.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Jotzu C, Alt E, Welte G, et al: Adipose
tissue-derived stem cells differentiate into carcinoma-associated
fibroblast-like cells under the influence of tumor-derived factors.
Anal Cell Pathol (Amst). 33:61–79. 2010. View Article : Google Scholar
|
|
25.
|
Heo SC, Lee KO, Shin SH, et al: Periostin
mediates human adipose tissue-derived mesenchymal stem
cell-stimulated tumor growth in a xenograft lung adenocarcinoma
model. Biochim Biophys Acta. 1813:2061–2070. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Shinagawa K, Kitadai Y, Tanaka M, et al:
Stroma-directed imatinib therapy impairs the tumor-promoting effect
of bone marrow-derived mesenchymal stem cells in an orthotopic
transplantation model of colon cancer. Int J Cancer. 132:813–823.
2012. View Article : Google Scholar
|
|
27.
|
Cho JA, Park H, Lim EH and Lee KW:
Exosomes from breast cancer cells can convert adipose
tissue-derived mesenchymal stem cells into myofibroblast-like
cells. Int J Oncol. 40:130–138. 2012.PubMed/NCBI
|
|
28.
|
Lis R, Touboul C, Raynaud CM, et al:
Mesenchymal cell interaction with ovarian cancer cells triggers
pro-metastatic properties. PLoS One. 7:e383402012. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Yan XL, Fu CJ, Chen L, et al: Mesenchymal
stem cells from primary breast cancer tissue promote cancer
proliferation and enhance mammosphere formation partially via
EGF/EGFR/Akt pathway. Breast Cancer Res Treat. 132:153–164. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Klopp AH, Lacerda L, Gupta A, et al:
Mesenchymal stem cells promote mammosphere formation and decrease
E-cadherin in normal and malignant breast cells. PLoS One.
5:e121802010. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Liu S, Ginestier C, Ou SJ, et al: Breast
cancer stem cells are regulated by mesenchymal stem cells through
cytokine networks. Cancer Res. 71:614–624. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
McLean K, Gong Y, Choi Y, et al: Human
ovarian carcinoma-associated mesenchymal stem cells regulate cancer
stem cells and tumorigenesis via altered BMP production. J Clin
Invest. 121:3206–3219. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Nishimura K, Semba S, Aoyagi K, Sasaki H
and Yokozaki H: Mesenchymal stem cells provide an advantageous
tumor microenvironment for the restoration of cancer stem cells.
Pathobiology. 79:290–306. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Hsu HS, Lin JH, Hsu TW, et al: Mesenchymal
stem cells enhance lung cancer initiation through activation of
IL-6/JAK2/STAT3 pathway. Lung Cancer. 75:167–177. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Tsai KS, Yang SH, Lei YP, et al:
Mesenchymal stem cells promote formation of colorectal tumors in
mice. Gastroenterology. 141:1046–1056. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Li HJ, Reinhardt F, Herschman HR and
Weinberg RA: Cancer-stimulated mesenchymal stem cells create a
carcinoma stem-cell niche via prostaglandin E2 signaling. Cancer
Discov. 2:840–855. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Thiery JP: Epithelial-mesenchymal
transitions in development and pathologies. Curr Opin Cell Biol.
15:740–746. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
39.
|
El-Haibi CP, Bell GW, Zhang J, et al:
Critical role for lysyl oxidase in mesenchymal stem cell-driven
breast cancer malignancy. Proc Natl Acad Sci USA. 109:17460–17465.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Xu Q, Wang L, Li H, et al: Mesenchymal
stem cells play a potential role in regulating the establishment
and maintenance of epithelial-mesenchymal transition in MCF7 human
breast cancer cells by paracrine and induced autocrine TGF-β. Int J
Oncol. 41:959–968. 2012.PubMed/NCBI
|
|
41.
|
Bhattacharya SD, Mi Z, Talbot LJ, Guo H
and Kuo PC: Human mesenchymal stem cell and epithelial hepatic
carcinoma cell lines in admixture: concurrent stimulation of
cancer-associated fibroblasts and epithelial-to-mesenchymal
transition markers. Surgery. 152:449–454. 2012. View Article : Google Scholar
|
|
42.
|
Jing Y, Han Z, Liu Y, et al: Mesenchymal
stem cells in inflammation microenvironment accelerates
hepatocellular carcinoma metastasis by inducing
epithelial-mesenchymal transition. PLoS One. 7:e432722012.
View Article : Google Scholar
|
|
43.
|
Kabashima-Niibe A, Higuchi H, Takaishi H,
et al: Mesenchymal stem cells regulate epithelial-to-mesenchymal
transition and tumor progression of pancreatic cancer cells. Cancer
Sci. 104:157–164. 2012. View Article : Google Scholar
|
|
44.
|
Halpern JL, Kilbarger A and Lynch CC:
Mesenchymal stem cells promote mammary cancer cell migration in
vitro via the CXCR2 receptor. Cancer Lett. 308:91–99. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
45.
|
Rhodes LV, Antoon JW, Muir SE, Elliott S,
Beckman BS and Burow ME: Effects of human mesenchymal stem cells on
ER-positive human breast carcinoma cells mediated through
ER-SDF-1/CXCR4 crosstalk. Mol Cancer. 9:2952010. View Article : Google Scholar : PubMed/NCBI
|
|
46.
|
Gallo M, De Luca A, Lamura L and Normanno
N: Zoledronic acid blocks the interaction between mesenchymal stem
cells and breast cancer cells: implications for adjuvant therapy of
breast cancer. Ann Oncol. 23:597–604. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47.
|
Karnoub AE, Dash AB, Vo AP, et al:
Mesenchymal stem cells within tumour stroma promote breast cancer
metastasis. Nature. 449:557–563. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
48.
|
Ye H, Cheng J, Tang Y, et al: Human bone
marrow-derived mesenchymal stem cells produced TGFbeta contributes
to progression and metastasis of prostate cancer. Cancer Invest.
30:513–518. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49.
|
Beckermann BM, Kallifatidis G, Groth A, et
al: VEGF expression by mesenchymal stem cells contributes to
angiogenesis in pancreatic carcinoma. Br J Cancer. 99:622–631.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
50.
|
Suzuki K, Sun R, Origuchi M, et al:
Mesenchymal stromal cells promote tumor growth through the
enhancement of neovascularization. Mol Med. 17:579–587. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
51.
|
Comsa S, Ciuculescu F and Raica M:
Mesenchymal stem cell-tumor cell cooperation in breast cancer
vasculogenesis. Mol Med Rep. 5:1175–1180. 2012.PubMed/NCBI
|
|
52.
|
Liu Y, Han ZP, Zhang SS, et al: Effects of
inflammatory factors on mesenchymal stem cells and their role in
the promotion of tumor angiogenesis in colon cancer. J Biol Chem.
286:25007–25015. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
53.
|
Zhu W, Huang L, Li Y, et al: Exosomes
derived from human bone marrow mesenchymal stem cells promote tumor
growth in vivo. Cancer Lett. 315:28–37. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54.
|
Krampera M, Glennie S, Dyson J, et al:
Bone marrow mesenchymal stem cells inhibit the response of naive
and memory antigen-specific T cells to their cognate peptide.
Blood. 101:3722–3729. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
55.
|
Tabera S, Perez-Simon JA, Diez-Campelo M,
et al: The effect of mesenchymal stem cells on the viability,
proliferation and differentiation of B-lymphocytes. Haematologica.
93:1301–1309. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
56.
|
Jiang XX, Zhang Y, Liu B, et al: Human
mesenchymal stem cells inhibit differentiation and function of
monocyte-derived dendritic cells. Blood. 105:4120–4126. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
57.
|
Nauta AJ, Kruisselbrink AB, Lurvink E,
Willemze R and Fibbe WE: Mesenchymal stem cells inhibit generation
and function of both CD34+-derived and monocyte-derived
dendritic cells. J Immunol. 177:2080–2087. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
58.
|
Sotiropoulou PA, Perez SA, Gritzapis AD,
Baxevanis CN and Papamichail M: Interactions between human
mesenchymal stem cells and natural killer cells. Stem Cells.
24:74–85. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
59.
|
Spaggiari GM and Moretta L: Cellular and
molecular interactions of mesenchymal stem cells in innate
immunity. Immunol Cell Biol. 91:27–31. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
60.
|
Batten P, Sarathchandra P, Antoniw JW, et
al: Human mesenchymal stem cells induce T cell anergy and
downregulate T cell allo-responses via the TH2 pathway: relevance
to tissue engineering human heart valves. Tissue Eng. 12:2263–2273.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
61.
|
Casiraghi F, Perico N and Remuzzi G:
Mesenchymal stromal cells to promote solid organ transplantation
tolerance. Curr Opin Organ Transplant. 18:51–58. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
62.
|
Reinders ME, de Fijter JW, Roelofs H, et
al: Autologous bone marrow-derived mesenchymal stromal cells for
the treatment of allograft rejection after renal transplantation:
results of a phase I study. Stem Cells Transl Med. 2:107–111. 2013.
View Article : Google Scholar
|
|
63.
|
Groh ME, Maitra B, Szekely E and Koc ON:
Human mesenchymal stem cells require monocyte-mediated activation
to suppress alloreactive T cells. Exp Hematol. 33:928–934. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
64.
|
Sato K, Ozaki K, Oh I, et al: Nitric oxide
plays a critical role in suppression of T-cell proliferation by
mesenchymal stem cells. Blood. 109:228–234. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
65.
|
Meisel R, Zibert A, Laryea M, Gobel U,
Daubener W and Dilloo D: Human bone marrow stromal cells inhibit
allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated
tryptophan degradation. Blood. 103:4619–4621. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
66.
|
Aggarwal S and Pittenger MF: Human
mesenchymal stem cells modulate allogeneic immune cell responses.
Blood. 105:1815–1822. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
67.
|
Patel SA, Meyer JR, Greco SJ, Corcoran KE,
Bryan M and Rameshwar P: Mesenchymal stem cells protect breast
cancer cells through regulatory T cells: role of mesenchymal stem
cell-derived TGF-beta. J Immunol. 184:5885–5894. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
68.
|
Han Z, Tian Z, Lv G, et al:
Immunosuppressive effect of bone marrow-derived mesenchymal stem
cells in inflammatory microenvironment favours the growth of B16
melanoma cells. J Cell Mol Med. 15:2343–2352. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
69.
|
Cheng J, Li L, Liu Y, Wang Z, Zhu X and
Bai X: Interleukin-1α induces immunosuppression by mesenchymal stem
cells promoting the growth of prostate cancer cells. Mol Med Rep.
6:955–960. 2012.
|
|
70.
|
Meads MB, Gatenby RA and Dalton WS:
Environment-mediated drug resistance: a major contributor to
minimal residual disease. Nat Rev Cancer. 9:665–674. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
71.
|
Sanchez CG, Penfornis P, Oskowitz AZ, et
al: Activation of autophagy in mesenchymal stem cells provides
tumor stromal support. Carcinogenesis. 32:964–972. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
72.
|
De Boeck A, Pauwels P, Hensen K, et al:
Bone marrow-derived mesenchymal stem cells promote colorectal
cancer progression through paracrine neuregulin 1/HER3 signalling.
Gut. 62:550–560. 2013.PubMed/NCBI
|
|
73.
|
Roodhart JM, Daenen LG, Stigter EC, et al:
Mesenchymal stem cells induce resistance to chemotherapy through
the release of platinum-induced fatty acids. Cancer Cell.
20:370–383. 2011. View Article : Google Scholar : PubMed/NCBI
|
